Clinical studies of plaque control agents: an overview.
Dental plaque is massed packed bacterial cells which accumulate on the supra- and subgingival surfaces of the teeth as well as on the oral mucosa. The microorganisms of plaque have been shown to be associated with both dental caries and periodontal disease. This overview of clinical studies of plaque control agents reviews the properties and effects of chemical compounds which have demonstrated a potential for the control of plaque microorganisms. The search for clinically effective antiplaque agents has been stimulated by findings in laboratory and animal studies of plaque dynamics. Based upon these in vitro and in vivo experiments, chemotherapeutic agents such as antibiotics, antiseptics, enzymes, detergents, bacteriosides, antimetabolites, and oxidizing agents have been evaluated against human plaque microorganisms using the ultimate biological model -- man. Continued study of chemotherapeutic agents should be encouraged because many of these drugs have been shown to be safe for human use and may require only the development of a delivery system to potentiate their concentration in a specific local site. Use of these chemotherapeutic agents, which can be self-administered, becomes an attractive way of providing the public with a cost-effective method of preventing caries and periodontal disease.
D000818:Animals; D001565:Benzoates / Q000627:therapeutic use; D001645:Biguanides / Q000627:therapeutic use; D002594:Cetylpyridinium / Q000627:therapeutic use; D002614:Chelating Agents / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D003731:Dental Caries / Q000209:etiology; D003773:Dental Plaque / Q000150:complications / Q000188:drug therapy / Q000382:microbiology / Q000517:prevention & control*; D003910:Dextranase / Q000627:therapeutic use; D003911:Dextrans / Q000378:metabolism; D004917:Erythromycin / Q000627:therapeutic use; D006801:Humans; D009910:Oral Hygiene; D010510:Periodontal Diseases / Q000209:etiology; D011135:Polysaccharides, Bacterial / Q000378:metabolism; D013291:Streptococcus / Q000378:metabolism; D014099:Toothbrushing; D014640:Vancomycin / Q000627:therapeutic use
D001565:Benzoates; D001645:Biguanides; D002614:Chelating Agents; D003911:Dextrans; D011135:Polysaccharides, Bacterial; D004917:Erythromycin; D014640:Vancomycin; D002594:Cetylpyridinium; D003910:Dextranase